Bringing HIV prevention meds to a family planning clinic
Part of Infections clinical trials.
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 16 years old or older.
- You must be a patient at the Women and Infants Hospital of Rhode Island Family Planning Clinic.
- You must speak English or Spanish.
- You must be able to make your own medical decisions.
- You are not currently seeking an abortion.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at whether giving a preventive HIV medicine called PrEP in a pediatric primary care setting can help increase its use among teens and young adults. The goal is to make it easier for young people to get PrEP and reduce their risk of HIV.
This study tests a program to help women at risk for HIV stay healthy while planning or having children. It provides prevention tools and support to reduce the chance of getting HIV.
This study tests whether pharmacies can offer HIV prevention medications (PrEP/PEP) with remote nurse support. It aims to make HIV prevention easier to access in the community.
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
This study is testing whether starting PrEP (daily pills to prevent HIV) right away in the emergency department helps people at high risk for HIV. It aims to make it easier to start protection before you leave the hospital.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.